Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists.
about
Regulation of Natural Killer Cell Function by STAT3Precision Medicine and Non-Colorectal Cancer Liver Metastases: Fiction or Reality?Carcinoma-associated fibroblasts: orchestrating the composition of malignancyConcurrent MEK targeted therapy prevents MAPK pathway reactivation during BRAFV600E targeted inhibition in a novel syngeneic murine glioma modelCombined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma.Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.Anti-human SIRPα antibody is a new tool for cancer immunotherapy.
P2860
Q26752551-1FEF895F-35A0-43B3-AFD9-B220819D25D6Q26764984-99D1B965-185A-4441-A3FB-6E8386799067Q28078667-20D1D63A-92EA-485C-B4AC-6CC040E97F22Q37689031-84A716E8-A0BF-4C2A-9800-89A11C53EF79Q42630498-5E92C788-1CBC-4110-90C1-AE4BE944FD50Q47850217-89EB1C22-798C-4380-A3C0-083BA2876487Q52688875-3C1F5AA6-C959-41F9-9656-8600250F37CD
P2860
Clinical Activity, Toxicity, Biomarkers, and Future Development of CTLA-4 Checkpoint Antagonists.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Clinical Activity, Toxicity, B ...... CTLA-4 Checkpoint Antagonists.
@en
type
label
Clinical Activity, Toxicity, B ...... CTLA-4 Checkpoint Antagonists.
@en
prefLabel
Clinical Activity, Toxicity, B ...... CTLA-4 Checkpoint Antagonists.
@en
P1433
P1476
Clinical Activity, Toxicity, B ...... CTLA-4 Checkpoint Antagonists.
@en
P2093
Jedd D Wolchok
Margaret K Callahan
P304
P356
10.1053/J.SEMINONCOL.2015.05.008
P577
2015-06-03T00:00:00Z